Fungal infections in solid organ transplantation

References

• Patterson JE. Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis 1999; 1: 229–236
   PubMedGoogle Scholar
• Husain S, Tollemar J, Dominguez EA, et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation 2003; 75: 2023–2029
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Boyken L, et al. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol 2004; 42: 3142–3146
   PubMed Web of Science ®Google Scholar
• Lumbreras C, Fernandez I, Velosa J, et al. Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. Clin Infect Dis 1995; 20: 514–520
   PubMed Web of Science ®Google Scholar
• Benedetti E, Gruessner AC, Troppmann C, et al. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg 1996; 183: 307–316
   PubMedGoogle Scholar
• Fungal infections Am J Transplant 2004; 4 (Suppl. 10):110–134.
   PubMedGoogle Scholar
• Kusne S, Furukawa H, bu-Elmagd K, et al. Infectious complications after small bowel transplantation in adults: an update. Transplant Proc 1996; 28: 2761–2762
   PubMedGoogle Scholar
• Guaraldi G, Cocchi S, Codeluppi M, et al. Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients. Transplantation 2005; 80: 1742–1748
   PubMed Web of Science ®Google Scholar
• Safdar N, Slattery WR, Knasinski V, et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis 2005; 40: 1413–1421
   PubMed Web of Science ®Google Scholar
• Takai K, Tollemar J, Wilczek HE, Groth CG. Urinary tract infections following renal transplantation. Clin Transplant 1998; 12: 19–23
   PubMed Web of Science ®Google Scholar
• Lyerova L, Lacha J, Skibova J, et al. Urinary tract infection in patients with urological complications after renal transplantation with respect to long-term function and allograft survival. Ann Transplant 2001; 6: 19–20
   PubMedGoogle Scholar
• Hellinger WC, Yao JD, Alvarez S, et al. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation 2002; 73: 1904–1909
   PubMed Web of Science ®Google Scholar
• Arnow PM, Carandang GC, Zabner R, Irwin ME. Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis 1996; 22: 997–1003
   PubMed Web of Science ®Google Scholar
• Hjortrup A, Rasmussen A, Hansen BA, et al. Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination. Transplant Proc 1997; 29: 3106–3110
   PubMedGoogle Scholar
• Wiesner RH, Hermans PE, Rakela J, et al. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation 1988; 45: 570–574
   PubMed Web of Science ®Google Scholar
• Lumbreras C, Cuervas-Mons V, Jara P, et al. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. J Infect Dis 1996; 174: 583–588
   PubMedGoogle Scholar
• Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; 131: 729–737
   PubMed Web of Science ®Google Scholar
• Sharpe MD, Ghent C, Grant D, et al. Efficacy and safety of itraconazole prophylaxis for fungal infections after orthotopic liver transplantation: a prospective, randomized, double-blind study. Transplantation 2003; 76: 977–983
   PubMedGoogle Scholar
• Cruciani M, Mengoli C, Malena M, et al. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl 2006; 12: 850–858
   PubMed Web of Science ®Google Scholar
• Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002; 51: 288–296
   PubMed Web of Science ®Google Scholar
• Singh N. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis 2000; 31: 545–553
   PubMed Web of Science ®Google Scholar
• Munoz P, Rodriguez C, Bouza E, et al. Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant 2004; 4: 636–643
   PubMed Web of Science ®Google Scholar
• Montoya JG, Chaparro SV, Celis D, et al. Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis 2003; 37: S281–S292
   Google Scholar
• Minari A, Husni R, Avery RK, et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002; 4: 195–200
   PubMedGoogle Scholar
• Husain S, Kwak EJ, Obman A, et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant 2004; 4: 796–802
   PubMed Web of Science ®Google Scholar
• Mehrad B, Paciocco G, Martinez FJ, et al. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest 2001; 119: 169–175
   PubMed Web of Science ®Google Scholar
• Westney GE, Kesten S, De Hoyos A, et al. Aspergillus infection in single and double lung transplant recipients. Transplantation 1996; 61: 915–919
   PubMed Web of Science ®Google Scholar
• Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26: 753–755
   PubMed Web of Science ®Google Scholar
• Cahill BC, Hibbs JR, Savik K, et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997; 112: 1160–1164
   PubMed Web of Science ®Google Scholar
• Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003; 22: 258–266
   PubMed Web of Science ®Google Scholar
• Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43: S49–58
   PubMed Web of Science ®Google Scholar
• Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation 1997; 64: 716–720
   PubMed Web of Science ®Google Scholar
• Kusne S, Torre-Cisneros J, Manez R, et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992; 166: 1379–1383
   PubMed Web of Science ®Google Scholar
• George MJ, Snydman DR, Werner BG, et al. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med 1997; 103: 106–113
   PubMed Web of Science ®Google Scholar
• Snydman DR, Falagas ME, Avery R, et al. Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study. Transplant Proc 2001; 33: 2571–2575
   PubMedGoogle Scholar
• Fortun J, Martin-Davila P, Moreno S, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl 2002; 8: 1065–1070
   PubMed Web of Science ®Google Scholar
• Gayowski T, Marino IR, Singh N, et al. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation 1998; 65: 499–504
   PubMedGoogle Scholar
• Pappas PG, Andes D, Schuster M, et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant 2006; 6: 386–391
   PubMed Web of Science ®Google Scholar
• Chan KM, Allen SA. Infectious pulmonary complications in lung transplant recipients. Semin Respir Infect 2002; 17: 291–302
   PubMedGoogle Scholar
• Higgins R, McNeil K, Dennis C, et al. Airway stenoses after lung transplantation: management with expanding metal stents. J Heart Lung Transplant 1994; 13: 774–778
   PubMed Web of Science ®Google Scholar
• Kubak BM. Fungal infection in lung transplantation. Transpl Infect Dis 2002; 4: 24–31
   PubMedGoogle Scholar
• Goldfarb NS, Avery RK, Goormastic M, et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001; 71: 242–246
   PubMed Web of Science ®Google Scholar
• Crespo MM, Raza K, Johnson BA , et al. Risk of pulmonary aspergillosis after bronchial stent placement in lung transplant (LTX) recipients, Abstract 66. International Society of Heart and Lung Transplantation (ISHLT), Madrid April 2006..
   Google Scholar
• Nunley DR, Ohori P, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 1998; 114: 1321–1329
   PubMed Web of Science ®Google Scholar
• Grossi P, Farina C, Fiocchi R, Dalla GD. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000; 70: 112–116
   PubMed Web of Science ®Google Scholar
• Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144: 552–556
   PubMed Web of Science ®Google Scholar
• Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003; 22: 258–266
   PubMed Web of Science ®Google Scholar
• Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999; 78: 123–138
   PubMed Web of Science ®Google Scholar
• Paterson DL, Singh N, Gayowski T, Marino IR. Pulmonary nodules in liver transplant recipients. Medicine (Baltimore) 1998; 77: 50–58
   PubMedGoogle Scholar
• Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis 2003; 36: 46–52
   PubMed Web of Science ®Google Scholar
• Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18: 44–69
   PubMed Web of Science ®Google Scholar
• Singh N, Pruett TL, Houston S, et al. Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl 2006; 12: 1205–1209
   PubMed Web of Science ®Google Scholar
• Brown RS., Jr, Lake JR, Katzman BA, et al. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation 1996; 61: 666–669
   PubMed Web of Science ®Google Scholar
• Kusne S, Torre-Cisneros J, Manez R, et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 1992; 166: 1379–1383
   PubMed Web of Science ®Google Scholar
• Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33: 1824–1833
   PubMed Web of Science ®Google Scholar
• Weiland D, Ferguson RM, Peterson PK, et al. Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg 1983; 198: 622–629
   PubMed Web of Science ®Google Scholar
• Kwak EJ, Husain S, Obman A, et al. Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 2004; 42: 435–438
   PubMed Web of Science ®Google Scholar
• Fortun J, Martin-Davila P, Alvarez ME, et al. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation 2001; 71: 145–149
   PubMed Web of Science ®Google Scholar
• Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42: 1417–1727
   PubMed Web of Science ®Google Scholar
• Husain S, Paterson DL, Studer S , et al. Prospective assessment of Platelia™ Aspergillus EIA in the bronchoalveolar lavage fluid for the early diagnosis of invasive aspergillosis (IA) in lung transplant recipients. World Transplant Congress, Boston, 2006, Abstract 2741.
   Google Scholar
• Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1 – > 3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol 1997; 35: 371–374
   PubMedGoogle Scholar
• Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415
   PubMed Web of Science ®Google Scholar
• Monforte V, Roman A, Gavalda J, et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant 2001; 20: 1274–1281
   PubMed Web of Science ®Google Scholar
• Drew RH, Dodds Ashley E, Benjamin DK., Jr, et al. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Transplantation 2004; 77: 232–237
   PubMed Web of Science ®Google Scholar
• Singh N, Limaye AP, Forrest G, et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 2006; 81: 320–326
   PubMed Web of Science ®Google Scholar
• Hamacher J, Spiliopoulos A, Kurt AM, Nicod LP. Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group. Eur Respir J 1999; 13: 180–186
   PubMed Web of Science ®Google Scholar
• Monforte V, Roman A, Gavalda J, et al. Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients. Transplantation 2003; 75: 1571–1574
   PubMed Web of Science ®Google Scholar
• Calvo V, Borro JM, Morales P, et al. Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. Chest 1999; 115: 1301–1304
   PubMed Web of Science ®Google Scholar
• Husain S, Paterson DL, Studer S, et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006; 12: 3008–3016
   Google Scholar
• Singh N, Paterson DL, Gayowski T, Wagener MM, Marino IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation 2001; 71: 910–913
   PubMedGoogle Scholar
• Fortun J, Martin-Davila P, Moreno S, et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother 2003; 52: 813–819
   PubMed Web of Science ®Google Scholar
• Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation 1995; 59: 45–50
   PubMed Web of Science ®Google Scholar
• Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001; 7: 375–381
   PubMed Web of Science ®Google Scholar
• Wu G, Vilchez RA, Eidelman B, et al. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis 2002; 4: 183–188
   PubMedGoogle Scholar
• Vilchez RA, Fung J, Kusne S. Cryptococcosis in organ transplant recipients: an overview. Am J Transplant 2002; 2: 575–580
   PubMed Web of Science ®Google Scholar
• Jabbour N, Reyes J, Kusne S, Martin M, Fung J. Cryptococcal meningitis after liver transplantation. Transplantation 1996; 61: 146–149
   PubMed Web of Science ®Google Scholar
• John GT, Mathew M, Snehalatha E, et al. Cryptococcosis in renal allograft recipients. Transplantation 1994; 58: 855–856
   PubMedGoogle Scholar
• Silveira FP, Husain S, Kwak EJ, Paterson DL. Cryptococcosis and tolerogenic immunosuppressive protocols. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, December, 2005; Abstract M-970.
   Google Scholar
• Singh N, Gayowski T, Wagener MM, Marino IR. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. Clin Transplant 1997; 11: 66–70
   PubMed Web of Science ®Google Scholar
• Vilchez RA, Irish W, Lacomis J, et al. The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) 2001; 80: 308–312
   PubMed Web of Science ®Google Scholar
• Neuville S, Dromer F, Morin O, et al. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis 2003; 36: 337–347
   PubMedGoogle Scholar
• Singh N, Lortholary O, Alexander BD, et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 2005; 40: 1756–1761
   PubMed Web of Science ®Google Scholar
• Singh N, Lortholary O, Alexander BD, et al. Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation 2005; 80: 1131–1133
   PubMedGoogle Scholar
• Mueller NJ, Fishman JA. Asymptomatic pulmonary cryptococcosis in solid organ transplantation: report of four cases and review of the literature. Transpl Infect Dis 2003; 5: 140–143
   PubMedGoogle Scholar
• Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 710–718
   PubMed Web of Science ®Google Scholar
• Singh N, Lortholary O, Alexander BD, et al. Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation 2005; 80: 1033–1039
   PubMed Web of Science ®Google Scholar
• Strategies for safe living following solid organ transplantation Am J Transplant 2004; 4: 156–159.
   PubMedGoogle Scholar
• Nosanchuk JD, Shoham S, Fries BC, et al. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med 2000; 132: 205–208
   PubMed Web of Science ®Google Scholar
• Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37: 221–229
   PubMed Web of Science ®Google Scholar
• Nucci M. Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003; 16: 607–612
   PubMed Web of Science ®Google Scholar
• Arney KL, Tiernan R, Judson MA. Primary pulmonary involvement of Fusarium solani in a lung transplant recipient. Chest 1997; 112: 1128–1130
   PubMedGoogle Scholar
• Cocuroccia B, Gaido J, Gubinelli E, Annessi G, Girolomoni G. Localized cutaneous hyalohyphomycosis caused by a Fusarium species infection in a renal transplant patient. J Clin Microbiol 2003; 41: 905–907
   PubMed Web of Science ®Google Scholar
• Garbino J, Uckay I, Rohner P, Lew D, Van DC. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Transpl Int 2005; 18: 613–618
   PubMed Web of Science ®Google Scholar
• Girardi M, Glusac EJ, Imaeda S. Subcutaneous Fusarium foot abscess in a renal transplant patient. Cutis 1999; 63: 267–270
   PubMed Web of Science ®Google Scholar
• Guinvarc'h A, Guilbert L, Marmorat-Khuong A, et al. Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses 1998; 41: 59–61
   PubMedGoogle Scholar
• Herbrecht R, Kessler R, Kravanja C, et al. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. J Heart Lung Transplant 2004; 23: 1451–1454
   PubMed Web of Science ®Google Scholar
• Kivivuori SM, Hovi L, Vettenranta K, Saarinen-Pihkala UM. Invasive fusariosis in two transplanted children. Eur J Pediatr 2004; 163: 692–693
   PubMedGoogle Scholar
• Sampathkumar P, Paya CV. Fusarium infection after solid-organ transplantation. Clin Infect Dis 2001; 32: 1237–1240
   PubMed Web of Science ®Google Scholar
• Gamis AS, Gudnason T, Giebink GS, Ramsay NK. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis 1991; 13: 1077–1088
   PubMedGoogle Scholar
• Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35: 909–920
   PubMed Web of Science ®Google Scholar
• Raad II, Hachem RY, Herbrecht R, et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006; 42: 1398–1403
   PubMed Web of Science ®Google Scholar
• Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027–1033
   PubMed Web of Science ®Google Scholar
• Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 2002; 81: 333–348
   PubMed Web of Science ®Google Scholar
• Husain S, Munoz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005; 40: 89–99
   PubMed Web of Science ®Google Scholar
• Agger WA, Andes D, Burgess JW. Exophiala jeanselmei infection in a heart transplant recipient successfully treated with oral terbinafine. Clin Infect Dis 2004; 38: 3112–115[Epub]
   Google Scholar
• Chua JD, Gordon SM, Banbury J, Hall GS, Procop GW. Relapsing Exophiala jeanselmei phaeohyphomycosis in a lung-transplant patient. Transpl Infect Dis 2001; 3: 235–238
   PubMedGoogle Scholar
• Farina C, Punithaligham E, Ruggenenti P, Goglio A. Phaeohyphomycotic soft tissue disease caused by Pleurophomopsis lignicola in a kidney transplant patient. J Med Microbiol 1997; 46: 699–703
   PubMed Web of Science ®Google Scholar
• Jha V, Krishna VS, Chakrabarti A, et al. Subcutaneous phaeohyphomycosis in a renal transplant recipient: a case report and review of the literature. Am J Kidney Dis 1996; 28: 137–139
   PubMed Web of Science ®Google Scholar
• Pena-Penabad C, Duran MT, Yebra MT, et al. Chromomycosis due to Exophiala jeanselmei in a renal transplant recipient. Eur J Dermatol 2003; 13: 305–307
   PubMed Web of Science ®Google Scholar
• Xu X, Low DW, Palevsky HI, Elenitsas R. Subcutaneous phaeohyphomycotic cysts caused by Exophiala jeanselmei in a lung transplant patient. Dermatol Surg 2001; 27: 343–346
   PubMedGoogle Scholar
• Yehia M, Thomas M, Pilmore H, Van Der MW, Dittmer I. Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients:three cases. Transplantation 2004; 77: 140–142
   PubMed Web of Science ®Google Scholar
• Aldape KD, Fox HS, Roberts JP, et al. Cladosporium trichoides cerebral phaeohyphomycosis in a liver transplant recipient. Report of a case. Am J Clin Pathol 1991; 95: 499–502
   PubMed Web of Science ®Google Scholar
• Anandi V, John TJ, Walter A, et al. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol 1989; 27: 2226–2229
   PubMed Web of Science ®Google Scholar
• Keyser A, Schmid FX, Linde HJ, Merk J, Birnbaum DE. Disseminated Cladophialophora bantiana infection in a heart transplant recipient. J Heart Lung Transplant 2002; 21: 503–505
   PubMed Web of Science ®Google Scholar
• Lee YM, Tambyah PA, Lee KH, Tan KC, Lim SG. Successful treatment of Xylohypha bantiana brain abscess mimicking invasive cerebral aspergillosis in a liver transplant recipient. J Infect 2003; 47: 348–351
   PubMed Web of Science ®Google Scholar
• Mazur JE, Judson MA. A case report of a dactylaria fungal infection in a lung transplant patient. Chest 2001; 119: 651–653
   PubMed Web of Science ®Google Scholar
• Vukmir RB, Kusne S, Linden P, et al. Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava in a liver transplant recipient. Clin Infect Dis 1994; 19: 714–719
   PubMed Web of Science ®Google Scholar
• Wang TK, Chiu W, Chim S, et al. Disseminated Ochroconis gallopavum infection in a renal transplant recipient: the first reported case and a review of the literature. Clin Nephrol 2003; 60: 415–423
   PubMed Web of Science ®Google Scholar
• Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis 1997; 24: 369–374
   PubMedGoogle Scholar
• Gallelli B, Viviani M, Nebuloni M, et al. Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of the literature. J Nephrol 2006; 19: 668–672
   PubMed Web of Science ®Google Scholar
• Gilaberte M, Bartralot R, Torres JM, et al. Cutaneous alternariosis in transplant recipients: clinicopathologic review of 9 cases. J Am Acad Dermatol 2005; 52: 653–659
   PubMed Web of Science ®Google Scholar
• Garcia-Diaz JB, Baumgarten K. Phaeohyphomycotic infections in solid organ transplant patients. Semin Respir Infect 2002; 17: 303–309
   PubMedGoogle Scholar
• Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis 2001; 14: 679–684
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–917
   PubMed Web of Science ®Google Scholar
• Pagano L, Girmenia C, Mele L, et al. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica 2001; 86: 862–870
   PubMed Web of Science ®Google Scholar
• Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 2004; 350: 950–952
   PubMed Web of Science ®Google Scholar
• Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 2004; 39: 743–746
   PubMed Web of Science ®Google Scholar
• Kauffman CA. Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 2004; 39: 588–590
   PubMed Web of Science ®Google Scholar
• Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37: 221–229
   PubMed Web of Science ®Google Scholar
• Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995; 20: 617–620
   PubMedGoogle Scholar
• Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006; 25: 215–219
   PubMed Web of Science ®Google Scholar
• Jimenez C, Lumbreras C, Aguado JM, et al. Successful treatment of mucor infection after liver or pancreas-kidney transplantation. Transplantation 2002; 73: 476–480
   PubMed Web of Science ®Google Scholar
• Dannaoui E, Meis JF, Loebenberg D, Verweij PE. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 2003; 47: 3647–3650
   PubMed Web of Science ®Google Scholar
• Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 2002; 46: 2310–2312
   PubMed Web of Science ®Google Scholar
• Wright PW, Pappagianis D, Wilson M, et al. Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003; 37: 1265–1269
   PubMedGoogle Scholar
• Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004; 42: 2347–2349
   PubMedGoogle Scholar
• Tripathy U, Yung GL, Kriett JM, et al. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002; 73: 306–308
   PubMedGoogle Scholar
• Braddy CM, Heilman RL, Blair JE. Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant 2006; 6: 340–345
   PubMedGoogle Scholar
• Blair JE. Coccidioidomycosis in liver transplantation. Liver Transpl 2006; 12: 31–39
   PubMedGoogle Scholar
• Hall KA, Sethi GK, Rosado LJ, et al. Coccidioidomycosis and heart transplantation. J Heart Lung Transplant 1993; 12: 525–526
   PubMedGoogle Scholar
• Logan JL, Blair JE, Galgiani JN. Coccidioidomycosis complicating solid organ transplantation. Semin Respir Infect 2001; 16: 251–256
   PubMedGoogle Scholar
• Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001; 33: 1536–1544
   PubMed Web of Science ®Google Scholar
• Blair JE, Douglas DD. Coccidioidomycosis in liver transplant recipients relocating to an endemic area. Dig Dis Sci 2004; 49: 1981–1985
   PubMed Web of Science ®Google Scholar
• Blair JE, Coakley B, Santelli AC, Hentz JG, Wengenack NL. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia 2006; 162: 317–324
   PubMed Web of Science ®Google Scholar
• Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41: 1217–1223
   PubMed Web of Science ®Google Scholar
• Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis 2003; 5: 3–8
   PubMedGoogle Scholar
• Kauffman CA. Endemic mycoses after hemopoietic stem cell or solid organ transplantation. Transplant Infections, RA Bowden, P Ljungman, CV Paya. Lippincott Williams & Wilkins, Philadelphia 2003
   Google Scholar
• Blair JE. Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation. Transpl Infect Dis 2004; 6: 74–76
   PubMedGoogle Scholar
• Brewer JH, Parrott CL, Rimland D. Disseminated coccidioidomycosis in a heart transplant recipient. Sabouraudia 1982; 20: 261–265
   PubMedGoogle Scholar
• Davies SF, Khan M, Sarosi GA. Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area. Am J Med 1978; 64: 94–100
   PubMedGoogle Scholar
• Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients. Two large urban outbreaks. Arch Intern Med 1983; 143: 703–707
   PubMed Web of Science ®Google Scholar
• Peddi VR, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant 1996; 10: 160–165
   PubMed Web of Science ®Google Scholar
• Vail GM, Young RS, Wheat LJ, et al. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002; 4: 148–151
   PubMedGoogle Scholar
• Freifeld AG, Iwen PC, Lesiak BL, et al. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7: 109–115
   PubMedGoogle Scholar
• Buck BE, Malinin TI, Davis JH. Transmission of histoplasmosis by organ transplantation. N Engl J Med 2001; 344: 310
   PubMedGoogle Scholar
• Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000; 343: 1163–1166
   PubMed Web of Science ®Google Scholar
• Wong SY, Allen DM. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report. Clin Infect Dis 1992; 14: 232–234
   PubMed Web of Science ®Google Scholar
• Botterel F, Romand S, Saliba F, et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999; 18: 662–664
   PubMed Web of Science ®Google Scholar
• Wheat LJ. Laboratory diagnosis of histoplasmosis: update 2000. Semin Respir Infect 2001; 16: 131–140
   PubMedGoogle Scholar
• Wheat LJ, Kohler RB, Tewari RP. Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens. N Engl J Med 1986; 314: 83–88
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Connolly P, Durkin M, et al. False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies. Transpl Infect Dis 2004; 6: 23–27
   PubMedGoogle Scholar
• Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997; 24: 1169–1171
   PubMed Web of Science ®Google Scholar
• Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 688–695
   PubMed Web of Science ®Google Scholar
• Screening of donor and recipient prior to solid organ transplantation Am J Transplant 2004; 4: 10–20.
   PubMedGoogle Scholar
• Klein BS, Vergeront JM, Davis JP. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect 1986; 1: 29–39
   PubMedGoogle Scholar
• Chapman SW. Blastomyces dermatitidis. Principles and Practice of Infectious Diseases, GL Mandell, JE Bennett, R Dolin. Elsevier, Philadelphia 2005
   Google Scholar
• Chapman SW, Bradsher RW., Jr, Campbell GD., Jr, Pappas PG, Kauffman CA. Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 679–683
   PubMed Web of Science ®Google Scholar
• Durkin M, Witt J, Lemonte A, Wheat B, Connolly P. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004; 42: 4873–4875
   PubMed Web of Science ®Google Scholar